2015-04-30

[DIV28SUPER] Statement from APA in response to April 30, 2015 New York Times article

April 30, 2015

APA Public and Member Communications

 

Statement from APA in response to April 30, 2015 New York Times article

 

Members have contacted the APA Central Office expressing concerns about this morning's New York Times article which recirculated allegations about APA support for the CIA's torture program.  We understand those concerns.  APA senior governance and staff take the allegations of support for torture and the public misunderstanding they have created very seriously.  

When James Risen first made his allegations last October we released a statement refuting them(http://www.apa.org/news/press/releases/2014/11/risen-allegations.aspx). However, due to the seriousness of the allegations we believed that they required an independent and definitive review.  As you know, outside attorney David Hoffman of the law firm Sidley Austin was asked to conduct such a review.  Mr. Hoffman has broad experience in conducting independent reviews and an unchallenged reputation for independence and integrity.  His work on the review is ongoing.  

Mr. Hoffman's review is fully independent and it is important that it be perceived as such by the public.  Toward that end, and while the review is on-going, APA is not making any comment on the merit of the allegations.  Mr. Hoffman has full and unfettered access to the people and documents he deems necessary for the review – to the extent APA can control such access.  His report will determine the facts.  While we are hopeful that the report will clear APA's name (especially since the allegations are so antithetical to psychology's mission and APA's actual work) we believe that it is important that Mr. Hoffman be given as much time as he needs to do a thorough review.    Regardless of the outcome, we believe the independent review is critical to the Association being able to move forward.

We tentatively expect the review to be completed later this spring or early this summer but the final completion schedule will be determined by Mr. Hoffman.  Once it is completed and the report received and reviewed by the APA Board of Directors (with input from the APA Council of Representatives) it will be made public, in its entirety, along with any initial responsive actions that APA determines are needed. The Council will also have a second opportunity to review the report and take additional actions during its August meeting.

-2-

When the report is released, we will undertake a proactivecommunications program to inform members and the general public of the report findings.  That outreach will include contact with national and international media, social media outreach and a same-day communications to all APA members.

In terms of what APA has done today, we have shared a response statement with media and have also posted a response to Facebook and Twitter.   More information is also available on the APA website. If you are interested in a full chronology of APA's action and policies concerning national security interrogations see:

http://www.apa.org/news/press/statements/interrogations.aspx

 


Posted by at No comments:

2015-04-24

[DIV28_ANNOUNCEMENT] UAMS postdoctoral position

POST-DOCTORAL POSITIONS IN DRUG ABUSE PHARMACOLOGY AND TREATMENT AT THE UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES

 

We are currently seeking Post-Doctoral Fellows with strong technical skills in preclinical models of drug abuse, and broader interest in the science of drug addiction, for positions within two NIH/NIDA R01 projects "Antibody Gene Therapy for Methamphetamine Abuse," (Eric Peterson PI) and "Pharmacology and Therapy for MDPV and alpha-PVP Like Drugs of Abuse" (Michael Owens, PI) within the Department of Pharmacology and Toxicology, and our NIH/NIDA T32 "Translational Training in Addiction" (Clint Kilts, PI) at the University of Arkansas for Medical Sciences in Little Rock. The selected candidates will become members of our interdisciplinary collaborating laboratories with ongoing, funded projects related to development of novel pharmacotherapeutics for psychostimulant addiction and toxicities. The T32 fellowship position is funded for two years, while the R01-supported positions could be funded for up to 3 years.

 

Our laboratories within the Department of Pharmacology and Toxicology are especially focused on (1) using behavioral pharmacology assays to understand the abuse-related effects of drugs (i.e., intravenous self-administration, drug discrimination) as well as their persistent effects on physiology and behavior (i.e., biotelemetry of locomotor activity, thermoregulation and cardiovascular effects, as well as assays relevant to psychosis, learning and memory), (2) designing novel antibody-based medications against psychostimulants, which slow entry of these drugs into the brain by binding them in the blood. A synthesis of these two areas of research allows us to test the therapeutic potential of these novel pharmacotherapies using a range of in vitro and in vivo models, and provides a fertile interdisciplinary training environment for fellows. Our drug abuse research group is part of an extensive network of addiction science efforts across several research Centers and Colleges at UAMS, including analytical chemistry and product surveillance at the Arkansas Department of Health, clinical scientists at the Psychiatric Research Institute and the Arkansas Children's Hospital, community-based research programs through the Division of Health Services Research, and our own pharmacology laboratories within the College of Medicine. Successful candidates will have strong communication skills and clear technical expertise, with a focus on either in vitro (e.g., expression analysis, Western blots, and receptor binding assays) or in vivo (e.g., operant behavior, locomotor activity) models. Demonstrated ability to apply more advanced tools (e.g., pharmacokinetic modeling, HPLC separation and detection in biological samples), and the ability to integrate in vivo and in vitro measures will be an advantage. The ability to publish research findings is important for these training positions. Candidates will have completed an MD or Ph.D. or equivalent degree in a relevant discipline (e.g., biomedical engineering, pharmacology, neuroscience, biological psychology, etc.). The University of Arkansas for Medical Sciences is an Equal Opportunity / Affirmative Action Employer. Minorities and women are strongly encouraged to apply. US Citizenship or Permanent Resident status (green card) is required. Applications will be considered until the position is filled. Please e-mail an up-to-date CV, the names of 3 references, and a one-page letter of interest describing your potential fit for the position to Associate Professor of Pharmacology and Toxicology Dr. William Fantegrossi (WEFantegrossi@uams.edu).

 

For more information contact:

    William Fantegrossi, Ph.D.

    Email: WEFantegrossi@uams.edu


               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
Associate Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are
confidential and are intended solely for the addressee. The information
may also be legally privileged. This transmission is sent in trust, for
the sole purpose of delivery to the intended recipient. If you have
received this transmission in error, any use, reproduction or
dissemination of this transmission is strictly prohibited. If you are
not the intended recipient, please immediately notify the sender by
reply e-mail or at (859) 257-5383 and delete this message and its
attachments, if any.
Posted by at No comments:

2015-04-16

[DIV28SUPER] Fwd: [NDEWS-NETWORK] NDEWS Network: E-Cigarettes, New Findings from the 2014 National Youth Tobacco Survey



Sent from my iPhone

Begin forwarded message:

From: "Eleanor E. Artigiani" <eartigia@UMD.EDU>
Date: April 16, 2015 at 5:41:28 PM EDT
To: NDEWS-NETWORK@LISTSERV.UMD.EDU
Subject: [NDEWS-NETWORK] NDEWS Network: E-Cigarettes, New Findings from the 2014 National Youth Tobacco Survey
Reply-To: "Eleanor E. Artigiani" <eartigia@UMD.EDU>

The NDEWS Coordinating Center thought you would be interested to know that CDC and FDA released results from the 2014 National Youth Tobacco Survey (YTS) this afternoon. The results discussed in the press release "show that current e-cigarette use (use on at least 1 day in the past 30 days) among high school students increased from 4.5 percent in 2013 to 13.4 percent in 2014, rising from approximately 660,000 to 2 million students. Among middle school students, current e-cigarette use more than tripled from 1.1 percent in 2013 to 3.9 percent in 2014—an increase from approximately 120,000 to 450,000 students. This is the first time since the survey started collecting data on e-cigarettes in 2011 that current e-cigarette use has surpassed current use of every other tobacco product overall, including conventional cigarettes. (CDC, 4/16/15)"

The CDC press release has been picked up by numerous news outlets. Here are links to the press release, the MMWR article, and stories put out today by the New York Times and Reuters.

 

CDC Press Release: http://www.cdc.gov/media/releases/2015/p0416-e-cigarette-use.html

MMWR: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6414a3.htm?s_cid=mm6414a3_w

New York Times: http://www.nytimes.com/2015/04/17/health/use-of-e-cigarettes-rises-sharply-among-teenagers-report-says.html

Reuters: http://news.yahoo.com/e-cigarette-soared-smoking-rate-fell-among-u-170831445--finance.html;_ylt=A0LEVjr7IzBV14wA8IgnnIlQ;_ylu=X3oDMTEzaXFocm5pBGNvbG8DYmYxBHBvcwMxBHZ0aWQDWUhTMDAzXzEEc2VjA3Nj

 

Erin Artigiani

Deputy Director for Policy

Center for Substance Abuse Research (CESAR)

4321 Hartwick Rd, Ste 501

College Park, MD 20740

301-405-9794

410-746-0793 (cell)

eartigia@umd.edu

www.cesar.umd.edu

www.mdcsl.org

 



You have received this email message as a member of the NDEWS Network discussion list. You can delete yourself from the list by sending an email to listserv@listserv.umd.edu with "unsubscribe ndews-network" (without the quotes) in the body of the email.
To change your settings, look through the archives, or subscribe a new subscriber, go to www.listserv.umd.edu/archives/ndews-network.html.
NDEWS is funded under NIDA Cooperative Agreement DA038360, awarded to the Center for Substance Abuse Research (CESAR) at the University of Maryland, College Park. Opinions expressed by participants on the NDEWS Network electronic mailing list may not represent those of CESAR, UMD, or NIDA. CESAR, UMD, and NIDA cannot attest to the accuracy of the statements made by participants of the NDEWS Network electronic mailing list.
Posted by at No comments:

2015-04-11

[DIV28SUPER] Removal

Please remove me from the list

Thanks josh crick

Sent from my Windows Phone
Posted by at No comments:

Re: [DIV28SUPER] Marijuana

Krista,


I saw your report from an television news station (YouTube) and found it fascinating about the results coming in. I also enjoyed the article from NYT that Dan sent. I know as well as you know, that A LOT of people take psychiatric medications every day, what are the effects of taking psychiatric medication (i.e, antidepressants, anti-anxiety, etc) on the brain in comparison to how marijuana effects the brain? I know the confounds of each since some people still smoke tobacco and mix marijuana with alcohol and some mix all three (alcohol, marijuana, psychiatric medications). Since our society and sometimes say it is "better living through chemistry", I wonder when you compare the taking of psychiatric medication or lets just narrow it down to antidepressants and anti-anxiety medication, which has the worse effects on the brain and behavior? Marijuana or psych meds from those categories I listed?


I ask this because adolescents, adults, college students will ask this. Adolescents will say that it doesn't have the man made "tar" and "nicotine" that marijuana has and therefore marijuana is "healthier".


Some random thoughts as the wave of legalization hits us...

Bill Hosmer, PhD


-----------------------------------------

From: "Krista Lisdahl"
To: mr.sanders@charter.net
Cc: DIV28SUPER@lists.apa.org
Sent: Sat, 11 Apr 2015 13:51:42 -0500
Subject: Re: [DIV28SUPER] Marijuana

There were too many articles for the listserv- but I wanted to share the two websites to the whole group. (Bill, let me know if you did not receive the articles.)

Best,
Krista


On Sat, Apr 11, 2015 at 1:48 PM, Krista Lisdahl <krista.medina@gmail.com> wrote:
Hello Bill,

My name is Krista Lisdahl, and studying the neurocognitive effects of Marijuana is my specialty area. I also consult on a lot of policy work (e.g., I serve on the DHHS cannabis board on WI, who is preparing a report on MJ policy considerations- e.g., cannabinoid science- esp medicinal uses, prohibition vs. decriminalization vs. legalization). I'm attaching 2 review articles,a couple articles re: medicinal research, and a few articles focused on MJ policy. There are tons of resources, but this will get you started. I'd also recommend you look the Marijuana Science Forum (http://marijuanascienceforum.org/) which tracks some of this research. The University of Washington also has a good site: http://learnaboutmarijuanawa.org/.

Best,

Krista

On Sat, Apr 11, 2015 at 1:24 PM, Bill Hosmer, PhD <mr.sanders@charter.net> wrote:

QUESTION:


1-I am looking for either or both excellent resources (e.g., texts, journal articles, etc.) on marijuana (good effects, bad, etc.). Since its legalization in some states and pushing quickly forward in others, I would like to know the pros/cons of using this. I primarily work with kids (3-22 y/o) and families and would like to know the scientific facts about this


Thanks in advance,

Bill Hosmer, PhD


-----------------------------------------

From: "Ronald Wood"
To: DIV28SUPER@LISTS.APA.ORG
Cc:
Sent: Sat, 11 Apr 2015 04:13:56 -0400
Subject: [DIV28SUPER] NYTimes: Milder Warning Opposed for Swedish Tobacco Item

http://www.nytimes.com/2015/04/11/science/milder-warning-opposed-for-swedish-tobacco-item.html?smid=nytcore-ipad-share&smprod=nytcore-ipad

Swedish Match argues its product, Snus — moist ground tobacco in a sachet to be tucked between the lip and the gum — is far less harmful than cigarettes.


Sent from my iPad
___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network




--
Krista M. Lisdahl, Ph.D.
(formerly Krista Lisdahl Medina)
krista.medina@gmail.com; medinak@uwm.edu 
Associate Professor
University of Wisconsin-Milwaukee
Psychology Department, Garland Hall Rm 224
2441 East Hartford Ave
Milwaukee, WI 53211 

 





--
Krista M. Lisdahl, Ph.D.
(formerly Krista Lisdahl Medina)
krista.medina@gmail.com; medinak@uwm.edu 
Associate Professor
University of Wisconsin-Milwaukee
Psychology Department, Garland Hall Rm 224
2441 East Hartford Ave
Milwaukee, WI 53211 

 
Posted by at No comments:

Re: [DIV28SUPER] Marijuana

There were too many articles for the listserv- but I wanted to share the two websites to the whole group. (Bill, let me know if you did not receive the articles.)

Best,
Krista


On Sat, Apr 11, 2015 at 1:48 PM, Krista Lisdahl <krista.medina@gmail.com> wrote:
Hello Bill,

My name is Krista Lisdahl, and studying the neurocognitive effects of Marijuana is my specialty area. I also consult on a lot of policy work (e.g., I serve on the DHHS cannabis board on WI, who is preparing a report on MJ policy considerations- e.g., cannabinoid science- esp medicinal uses, prohibition vs. decriminalization vs. legalization). I'm attaching 2 review articles,a couple articles re: medicinal research, and a few articles focused on MJ policy. There are tons of resources, but this will get you started. I'd also recommend you look the Marijuana Science Forum (http://marijuanascienceforum.org/) which tracks some of this research. The University of Washington also has a good site: http://learnaboutmarijuanawa.org/.

Best,

Krista

On Sat, Apr 11, 2015 at 1:24 PM, Bill Hosmer, PhD <mr.sanders@charter.net> wrote:

QUESTION:


1-I am looking for either or both excellent resources (e.g., texts, journal articles, etc.) on marijuana (good effects, bad, etc.). Since its legalization in some states and pushing quickly forward in others, I would like to know the pros/cons of using this. I primarily work with kids (3-22 y/o) and families and would like to know the scientific facts about this


Thanks in advance,

Bill Hosmer, PhD


-----------------------------------------

From: "Ronald Wood"
To: DIV28SUPER@LISTS.APA.ORG
Cc:
Sent: Sat, 11 Apr 2015 04:13:56 -0400
Subject: [DIV28SUPER] NYTimes: Milder Warning Opposed for Swedish Tobacco Item

http://www.nytimes.com/2015/04/11/science/milder-warning-opposed-for-swedish-tobacco-item.html?smid=nytcore-ipad-share&smprod=nytcore-ipad

Swedish Match argues its product, Snus — moist ground tobacco in a sachet to be tucked between the lip and the gum — is far less harmful than cigarettes.


Sent from my iPad
___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network




--
Krista M. Lisdahl, Ph.D.
(formerly Krista Lisdahl Medina)
krista.medina@gmail.com; medinak@uwm.edu 
Associate Professor
University of Wisconsin-Milwaukee
Psychology Department, Garland Hall Rm 224
2441 East Hartford Ave
Milwaukee, WI 53211 

 





--
Krista M. Lisdahl, Ph.D.
(formerly Krista Lisdahl Medina)
krista.medina@gmail.com; medinak@uwm.edu 
Associate Professor
University of Wisconsin-Milwaukee
Psychology Department, Garland Hall Rm 224
2441 East Hartford Ave
Milwaukee, WI 53211 

 


_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

Posted by at No comments:

Re: [DIV28SUPER] Marijuana

QUESTION:


1-I am looking for either or both excellent resources (e.g., texts, journal articles, etc.) on marijuana (good effects, bad, etc.). Since its legalization in some states and pushing quickly forward in others, I would like to know the pros/cons of using this. I primarily work with kids (3-22 y/o) and families and would like to know the scientific facts about this


Thanks in advance,

Bill Hosmer, PhD


-----------------------------------------

From: "Ronald Wood"
To: DIV28SUPER@LISTS.APA.ORG
Cc:
Sent: Sat, 11 Apr 2015 04:13:56 -0400
Subject: [DIV28SUPER] NYTimes: Milder Warning Opposed for Swedish Tobacco Item

http://www.nytimes.com/2015/04/11/science/milder-warning-opposed-for-swedish-tobacco-item.html?smid=nytcore-ipad-share&smprod=nytcore-ipad

Swedish Match argues its product, Snus — moist ground tobacco in a sachet to be tucked between the lip and the gum — is far less harmful than cigarettes.


Sent from my iPad
___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org
Posted by at No comments:
Subscribe to: Posts (Atom)